0
     

Report Added
Report already added
Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

AI in Medical Diagnostics Market by Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) - Global Forecast to 2029

The AI in medical diagnostics market is expected to reach $9.38 billion by 2029, at a CAGR of 36.2% from 2022–2029.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities for the AI in medical diagnostics market. The growth of this market is driven by the rising need for the adoption of AI in medical diagnosis due to the high rate of diagnostic errors, the growing shortage of medical specialists, and the increasing prevalence of chronic diseases.

In addition, factors such as high growth potential in emerging economies and the growing number of cross-industry partnerships and collaborations are expected to provide significant growth opportunities for this market. However, the reluctance of physicians to adopt AI technologies due to a lack of trust is expected to hamper the adoption of AI in medical diagnostics solutions and restrain the growth of this market. In addition, factors such as regulatory barriers and privacy and security concerns are the major challenges to the growth of this market.

Based on component, in 2022, the software segment is expected to account for the largest share of the AI in medical diagnostics market. The large market share of this segment is attributed to the benefits offered by software, such as automating the diagnosis process & triaging patients at high risk and aiding medical specialists in making quick and accurate medical decisions.
Based on specialty, in 2022, the brain & neurological segment is expected to account for the largest share of the AI in medical diagnostics market. The increasing prevalence of neurological disorders and increasing product approvals are driving the growth of this segment.

Based on modality, in 2022, the CT scan segment is expected to account for the largest share of this market. The large market share of this segment is attributed to the increasing number of patients undertaking CT scan imaging for the diagnosis of COVID-19 and the advantages offered by AI in CT scanning, such as the ability to reduce noise in medical images and reduce radiation dose, making it safer for the patients.

Based on end user, in 2022, the hospital segment is expected to account for the largest share of this market. The large market share of this segment is attributed to the early adoption of AI solutions by hospitals due to their high spending capabilities, the increasing number of patients with chronic diseases, the outbreak of COVID-19 pandemic, and shortage of medical specialists.
An in-depth analysis of the geographical scenario of the AI in medical diagnostics market provides detailed qualitative and quantitative insights across five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2022, North America is poised to command the largest share of the AI in medical diagnostics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the AI in medical diagnostics market are Siemens Healthineers AG (Germany), GE Healthcare (U.S.), Aidoc Medical Ltd. (Israel), International Business Machines Corporation (U.S.), AliveCor, Inc. (U.S.), VUNO Inc. (South Korea), Digital Diagnostics Inc. (U.S.), NovaSignal Corp. (U.S.), Riverain Technologies (U.S.), NANO-X IMAGING LTD (Israel), Imagen Technologies (U.S.), Koninklijke Philips N.V. (Netherlands), Agfa-Gevaert Group (Belgium), HeartFlow, Inc. (U.S.), and Arterys Inc. (U.S.).

Scope of the Report:
AI in Medical Diagnostics Market, by Component
•Software
•Services

AI in Medical Diagnostics Market, by Specialty
•Brain & Neurological
•Oncology
•Cardiac & Vascular
•Chest & Lung
•Obstetrics & Gynecology (OB-GYN)
•Other Specialties
Note: Other specialties include ophthalmology, dermatology, surgical pathology, nephrology, dentistry, hepatology, orthopedics, and endocrinology.

AI in Medical Diagnostics Market, by Modality
•MRI
•CT Scan
•X-ray
•Ultrasound
•Other Modalities
Note: Other modalities include ECG, PET scan, retinal optical imaging, and digital imaging

AI in Medical Diagnostics Market, by End User
•Hospitals
•Diagnostic Imaging Centers
•Others End Users
Note: Other end users include clinics, ambulatory care centers, clinical research organizations, and academic research centers.

AI in Medical Diagnostics Market, by Geography
•North America
U.S.
Canada
•Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
•Asia Pacific
China
Japan
India
Rest of APAC (RoAPAC)
•Latin America
•Middle East & Africa
Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Growing Need to Incorporate AI into Medical Diagnosis
4.2.2. Shortage of Healthcare Professionals
4.2.3. Rising Incidence of Chronic Diseases
4.3. Restraints
4.3.1. Reluctance to Adopt AI Technologies due to a Lack of Trust
4.4. Opportunities
4.4.1. High Potential in Emerging Economies
4.4.2. Growing Number of Cross-Industry Partnerships & Collaborations
4.5. Challenges
4.5.1. Regulatory Barriers
4.5.2. Privacy & Security Concerns
4.6. COVID-19 Impact
5. Global AI in Medical Diagnostics Market, by Component
5.1. Introduction
5.2. Software
5.3. Services
6. Global AI in Medical Diagnostics Market, by Specialty
6.1. Introduction
6.2. Brain & Neurological
6.3. Oncology
6.4. Cardiac & Vascular
6.5. Chest & Lung
6.6. Obstetrics & Gynecology (OB-GYN)
6.7. Other Specialties
7. Global AI in Medical Diagnostics Market, by Modality
7.1. Introduction
7.2. CT Scan
7.3. MRI
7.4. X-ray
7.5. Ultrasound
7.6. Other Modalities
8. Global AI in Medical Diagnostics Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Diagnostic Imaging Centers
8.4. Other End Users
9. Ai in Medical Diagnostics Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
11. Company Profiles
11.1. Siemens Healthineers AG
11.2. GE Healthcare (A Subsidiary of General Electric Company)
11.3. Aidoc Medical Ltd.
11.4. International Business Machines Corporation
11.5. AliveCor, Inc.
11.6. VUNO Inc.
11.7. Digital Diagnostics Inc.
11.8. NovaSignal Corporation
11.9. Riverain Technologies
11.10. NANO-X IMAGING LTD
11.11. Imagen Technologies
11.12. Koninklijke Philips N.V.
11.13. Arterys Inc.
11.14. HeartFlow, Inc.
11.15. Agfa Healthcare (A Subsidiary of Agfa-Gevaert N.V.)
12. Appendix
12.1. Questionnaire
12.2. Available Customization

List of Tables
Table 1 Global AI in Medical Diagnostics Market: Impact Analysis of Market Drivers (2022–2029)
Table 2 Shortfall of Healthcare Professionals, by Country/Region
Table 3 Number of Physicians Per 1,000 Population, by Country
Table 4 Global AI in Medical Diagnostics Market: Impact Analysis of Market Restraints (2022–2029)
Table 5 COVID-19 Cases and Deaths, by WHO Region (As of 22nd July 2022)
Table 6 Global AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 7 Global AI in Medical Diagnostics Software Market Size, by Country/Region, 2020–2029 (USD Million)
Table 8 Global AI in Medical Diagnostics Services Market Size, by Country/Region, 2020–2029 (USD Million)
Table 9 Global AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 10 Some of the FDA-approved AI Diagnostic Solutions for Brain & Neurological
Table 11 Global AI in Medical Diagnostics Market Size for Brain & Neurological, by Country/Region, 2020–2029 (USD Million)
Table 12 Some of the FDA Cleared Diagnostic AI Solutions for Oncology
Table 13 Global AI in Medical Diagnostics Market Size for Oncology, by Country/Region, 2020–2029 (USD Million)
Table 14 Some of the FDA Cleared Diagnostic AI Solutions for Cardiac & Vascular
Table 15 Global AI in Medical Diagnostics Market Size for Cardiac & Vascular, by Country/Region, 2020–2029 (USD Million)
Table 16 Some of the FDA-approved AI Diagnostic Solutions for Chest & Lung
Table 17 Global AI in Medical Diagnostics Market Size for Chest & Lung, by Country/Region, 2020–2029 (USD Million)
Table 18 Number of Childbirths Per Year (2020 Vs 2030)
Table 19 Global AI in Medical Diagnostics Market Size for Obstetrics & Gynecology (OB-GYN), by Country/Region, 2020–2029 (USD Million)
Table 20 Global AI in Medical Diagnostics Market Size for Other Specialties, by Country/Region, 2020–2029 (USD Million)
Table 21 Global AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 22 CT Scanners Per Million Inhabitants (2021 or the Latest Available)
Table 23 Recently FDA-approved CT Scan-Based Diagnostic AI Solutions
Table 24 Global AI in Medical Diagnostics Market Size for CT Scan, by Country/Region, 2020–2029 (USD Million)
Table 25 MRI Units Per Million Inhabitants (2021 or the Latest Available)
Table 26 Recently FDA-approved MRI-Based Diagnostic AI Solutions
Table 27 Global AI in Medical Diagnostics Market Size for MRI, by Country/Region, 2020–2029 (USD Million)
Table 28 Recently FDA-approved Mammography-Based Diagnostic AI Solutions
Table 29 Recently FDA-approved X-Ray-Based Diagnostic AI Solutions
Table 30 Global AI in Medical Diagnostics Market Size for X-Ray, by Country/Region, 2020–2029 (USD Million)
Table 31 Applications of AI in Ultrasound
Table 32 Recently FDA-approved X-Ray-Based Diagnostic AI Solutions
Table 33 Global AI in Medical Diagnostics Market Size for Ultrasound, by Country/Region, 2020–2029 (USD Million)
Table 34 Global AI in Medical Diagnostics Market Size for Other Modalities, by Country/Region, 2020–2029 (USD Million)
Table 39 Global AI in Medical Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 40 North America: AI in Medical Diagnostics Market Size, by Country, 2020–2029 (USD Million)
Table 41 North America: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 42 North America: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 43 North America: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million
Table 44 North America: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 45 U.S.: Key Macroindicators
Table 46 U.S.: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 47 U.S.: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 48 U.S.: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 49 U.S.: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 50 Canada: Key Macroindicators
Table 51 Canada: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 52 Canada: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 53 Canada: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 54 Canada: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 55 Europe: AI in Medical Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 56 Europe: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 57 Europe: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 58 Europe: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 59 Europe: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 60 Germany: Key Macroindicators
Table 61 Germany: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 62 Germany: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 63 Germany: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 64 Germany: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 65 U.K.: Current Prevalence as % of Population
Table 66 U.K.: Key Macroindicators
Table 67 U.K.: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 68 U.K.: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 69 U.K.: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 70 U.K.: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 71 France: Key Macroindicators
Table 72 France: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 73 France: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 74 France: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 75 France: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 76 Italy: Leading Causes of Deaths (2020)
Table 77 Italy: Key Macroindicators
Table 78 Italy: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 79 Italy: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 80 Italy: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 81 Italy: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 82 AI in Medical Diagnostics Start-Ups in Spain
Table 83 Spain: Key Macroindicators
Table 84 Spain: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 85 Spain: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 86 Spain: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 87 Spain: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 88 Estimated Number of New Cancer Cases From 2020 to 2030
Table 89 Rest of Europe: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 90 Rest of Europe: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 91 Rest of Europe: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 92 Rest of Europe: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 93 Asia-Pacific: AI in Medical Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 94 Asia-Pacific: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 95 Asia-Pacific: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 96 Asia-Pacific: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 97 Asia-Pacific: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 98 China: Key Macroindicators
Table 99 China: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 100 China: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 101 China: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 102 China: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 103 Japan: Key Macroindicators
Table 104 Japan: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 105 Japan: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 106 Japan: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 107 Japan: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 108 India: Key Macroindicators
Table 109 India: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 110 India: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 111 India: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 112 India: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 113 Estimated Number of New Cancer Cases From 2020 to 2030
Table 114 Rest of Asia-Pacific: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 115 Rest of Asia-Pacific: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 116 Rest of Asia-Pacific: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 117 Rest of Asia-Pacific: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 118 Latin America: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 119 Latin America: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 120 Latin America: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 121 Latin America: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 122 Middle East & Africa: AI in Medical Diagnostics Market Size, by Component, 2020–2029 (USD Million)
Table 123 Middle East & Africa: AI in Medical Diagnostics Market Size, by Specialty, 2020–2029 (USD Million)
Table 124 Middle East & Africa: AI in Medical Diagnostics Market Size, by Modality, 2020–2029 (USD Million)
Table 125 Middle East & Africa: AI in Medical Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 126 Recent Developments, by Company (2019–2022)

Report Title: Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region